复星医药AH齐涨，传新冠疫苗通过专家评审

24
8
Favorite

复星医药AH齐涨，传新冠疫苗通过专家评审

老虎资讯综合2021-07-15

7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。

据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。

复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（8）

宁可十年不将军
·2021-07-15
難道不打國產的不讓打？
Reply
Like
Report
圆润的石头
·2021-07-15
可以和滅活疫苗混打？
Reply
Like
Report
Jamesong
·2021-07-15
爲什麼不早批准？
Reply
Like
Report
Jet2017
·2021-07-15
都在等着呢
Reply
Like
Report
赞我的今年账户翻十倍
·2021-07-15
說好的利好出盡呢
Reply
1
Report
求金
·2021-07-15
[暗中觀察]
Reply
3
Report
Fold Replies
- 求金:
  [强]
  2021-07-15
  Reply
  Report
股海摩西
·2021-07-15
Zan
Reply
3
Report
Fold Replies
- 求金:
  [强]
  2021-07-15
  Reply
  Report
- 股海摩西:
  Zan
  2021-07-15
  Reply
  Report
麦基Zzzz
·2021-07-15
加強針？不是混打嗎？
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1134354713?lang=en_US&edition=fundamental","thumbnail":"https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419","is_english":false,"pubTime":"2021-07-15 09:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134354713","market":"hk","top_or_hot":-1,"title":"复星医药AH齐涨，传新冠疫苗通过专家评审","media":"老虎资讯综合","content":"<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药AH齐涨，传新冠疫苗通过专家评审</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药AH齐涨，传新冠疫苗通过专家评审\n</h2>\n\n<h4 class=\"meta\">\n\n2021-07-15 09:42 北京时间&nbsp;&nbsp;&nbsp;<strong>老虎资讯综合</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为...</p>\n\n<a href=\"None\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"600196","symbol_name":"复星医药","start_time":0,"source_url":null,"article_id":"1134354713","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134354713","pubTimestamp":1626313344,"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"150130":"医药A","600196":"复星医药","02196":"复星医药"},"translate_title":"Shanghai Fosun Pharmaceutical (Group) AH rose together, and COVID-19 vaccine passed the expert review","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/43586846253808ab16e6ec17c7a8607e","symbols_score_info":{"150130":0.9,"600196":0.9,"02196":0.9},"content_text":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":147609915,"gmtCreate":1626353799337,"gmtModify":1703758475030,"author":{"id":"3552187859584454","authorId":"3552187859584454","name":"宁可十年不将军","avatar":"https://static.tigerbbs.com/847e8bf5fbdde42dbf452eb3e06f39b8","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3552187859584454","idStr":"3552187859584454"},"htmlText":"難道不打國產的不讓打？","listText":"難道不打國產的不讓打？","text":"難道不打國產的不讓打？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/147609915","repostId":1134354713,"repostType":2,"repost":{"id":"1134354713","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626313344,"share":"https://ttm.financial/m/news/1134354713?lang=&edition=fundamental","pubTime":"2021-07-15 09:42","market":"hk","language":"zh","title":"复星医药AH齐涨，传新冠疫苗通过专家评审","url":"https://stock-news.laohu8.com/highlight/detail?id=1134354713","media":"老虎资讯综合","summary":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经","content":"<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药AH齐涨，传新冠疫苗通过专家评审</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药AH齐涨，传新冠疫苗通过专家评审\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-15 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419","relate_stocks":{"150130":"医药A","600196":"复星医药","02196":"复星医药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134354713","content_text":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":147027881,"gmtCreate":1626321740543,"gmtModify":1703757863056,"author":{"id":"3573866420125481","authorId":"3573866420125481","name":"圆润的石头","avatar":"https://static.tigerbbs.com/41344ac1b97f0a95b3a801d2fa88fd89","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3573866420125481","idStr":"3573866420125481"},"htmlText":"可以和滅活疫苗混打？","listText":"可以和滅活疫苗混打？","text":"可以和滅活疫苗混打？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/147027881","repostId":1134354713,"repostType":4,"repost":{"id":"1134354713","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626313344,"share":"https://ttm.financial/m/news/1134354713?lang=&edition=fundamental","pubTime":"2021-07-15 09:42","market":"hk","language":"zh","title":"复星医药AH齐涨，传新冠疫苗通过专家评审","url":"https://stock-news.laohu8.com/highlight/detail?id=1134354713","media":"老虎资讯综合","summary":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经","content":"<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药AH齐涨，传新冠疫苗通过专家评审</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药AH齐涨，传新冠疫苗通过专家评审\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-15 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419","relate_stocks":{"150130":"医药A","600196":"复星医药","02196":"复星医药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134354713","content_text":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":144744505,"gmtCreate":1626316653307,"gmtModify":1703757746441,"author":{"id":"3466588668728406","authorId":"3466588668728406","name":"Jamesong","avatar":"https://static.tigerbbs.com/6f6adc4e68e88a5881cd59e5b0a06547","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3466588668728406","idStr":"3466588668728406"},"htmlText":"爲什麼不早批准？","listText":"爲什麼不早批准？","text":"爲什麼不早批准？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/144744505","repostId":1134354713,"repostType":4,"repost":{"id":"1134354713","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626313344,"share":"https://ttm.financial/m/news/1134354713?lang=&edition=fundamental","pubTime":"2021-07-15 09:42","market":"hk","language":"zh","title":"复星医药AH齐涨，传新冠疫苗通过专家评审","url":"https://stock-news.laohu8.com/highlight/detail?id=1134354713","media":"老虎资讯综合","summary":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经","content":"<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药AH齐涨，传新冠疫苗通过专家评审</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药AH齐涨，传新冠疫苗通过专家评审\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-15 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419","relate_stocks":{"150130":"医药A","600196":"复星医药","02196":"复星医药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134354713","content_text":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":144761137,"gmtCreate":1626315003829,"gmtModify":1703757697558,"author":{"id":"3460824243893799","authorId":"3460824243893799","name":"Jet2017","avatar":"https://static.tigerbbs.com/c11ae55ec0562345c2b3032207464065","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3460824243893799","idStr":"3460824243893799"},"htmlText":"都在等着呢","listText":"都在等着呢","text":"都在等着呢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/144761137","repostId":1134354713,"repostType":2,"repost":{"id":"1134354713","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626313344,"share":"https://ttm.financial/m/news/1134354713?lang=&edition=fundamental","pubTime":"2021-07-15 09:42","market":"hk","language":"zh","title":"复星医药AH齐涨，传新冠疫苗通过专家评审","url":"https://stock-news.laohu8.com/highlight/detail?id=1134354713","media":"老虎资讯综合","summary":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经","content":"<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药AH齐涨，传新冠疫苗通过专家评审</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药AH齐涨，传新冠疫苗通过专家评审\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-15 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419","relate_stocks":{"150130":"医药A","600196":"复星医药","02196":"复星医药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134354713","content_text":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":144769604,"gmtCreate":1626314953208,"gmtModify":1703757694801,"author":{"id":"3569581951650623","authorId":"3569581951650623","name":"赞我的今年账户翻十倍","avatar":"https://static.tigerbbs.com/d1d63378f07d4231f465c7cd27356410","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3569581951650623","idStr":"3569581951650623"},"htmlText":"說好的利好出盡呢","listText":"說好的利好出盡呢","text":"說好的利好出盡呢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/144769604","repostId":1134354713,"repostType":4,"repost":{"id":"1134354713","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626313344,"share":"https://ttm.financial/m/news/1134354713?lang=&edition=fundamental","pubTime":"2021-07-15 09:42","market":"hk","language":"zh","title":"复星医药AH齐涨，传新冠疫苗通过专家评审","url":"https://stock-news.laohu8.com/highlight/detail?id=1134354713","media":"老虎资讯综合","summary":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经","content":"<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药AH齐涨，传新冠疫苗通过专家评审</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药AH齐涨，传新冠疫苗通过专家评审\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-15 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419","relate_stocks":{"150130":"医药A","600196":"复星医药","02196":"复星医药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134354713","content_text":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":144731391,"gmtCreate":1626313612313,"gmtModify":1703757656093,"author":{"id":"3573168884997306","authorId":"3573168884997306","name":"求金","avatar":"https://static.tigerbbs.com/869d585d3a198da2a97a46b697e6c522","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3573168884997306","idStr":"3573168884997306"},"htmlText":"[暗中觀察]&nbsp;","listText":"[暗中觀察]&nbsp;","text":"[暗中觀察]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/144731391","repostId":1134354713,"repostType":4,"repost":{"id":"1134354713","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626313344,"share":"https://ttm.financial/m/news/1134354713?lang=&edition=fundamental","pubTime":"2021-07-15 09:42","market":"hk","language":"zh","title":"复星医药AH齐涨，传新冠疫苗通过专家评审","url":"https://stock-news.laohu8.com/highlight/detail?id=1134354713","media":"老虎资讯综合","summary":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经","content":"<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药AH齐涨，传新冠疫苗通过专家评审</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药AH齐涨，传新冠疫苗通过专家评审\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-15 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419","relate_stocks":{"150130":"医药A","600196":"复星医药","02196":"复星医药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134354713","content_text":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5224356,"gmtCreate":1626313628852,"gmtModify":1663230989552,"authorId":3573168884997306,"author":{"id":3573168884997306,"idStr":"3573168884997306","authorId":3573168884997306,"name":"求金","avatar":"https://static.tigerbbs.com/869d585d3a198da2a97a46b697e6c522","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":144731391,"type":1,"supId":0,"prevId":0,"content":"[强]","text":"[强]","html":"[强]"}],"langContent":"CN"},{"id":144730289,"gmtCreate":1626313531141,"gmtModify":1703757652665,"author":{"id":"3580972018907173","authorId":"3580972018907173","name":"股海摩西","avatar":"https://static.tigerbbs.com/b4b3b2e60ed720da92ef4a446dcdaaf4","vip":1,"hat":"https://static.tigerbbs.com/2b6219675842600ebb42baa43c645832","crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3580972018907173","idStr":"3580972018907173"},"htmlText":"Zan","listText":"Zan","text":"Zan","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/144730289","repostId":1134354713,"repostType":4,"repost":{"id":"1134354713","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626313344,"share":"https://ttm.financial/m/news/1134354713?lang=&edition=fundamental","pubTime":"2021-07-15 09:42","market":"hk","language":"zh","title":"复星医药AH齐涨，传新冠疫苗通过专家评审","url":"https://stock-news.laohu8.com/highlight/detail?id=1134354713","media":"老虎资讯综合","summary":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经","content":"<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药AH齐涨，传新冠疫苗通过专家评审</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药AH齐涨，传新冠疫苗通过专家评审\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-15 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419","relate_stocks":{"150130":"医药A","600196":"复星医药","02196":"复星医药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134354713","content_text":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5224358,"gmtCreate":1626313636894,"gmtModify":1663230990145,"authorId":3573168884997306,"author":{"id":3573168884997306,"idStr":"3573168884997306","authorId":3573168884997306,"name":"求金","avatar":"https://static.tigerbbs.com/869d585d3a198da2a97a46b697e6c522","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":144730289,"type":1,"supId":0,"prevId":0,"content":"[强]","text":"[强]","html":"[强]"},{"id":5224341,"gmtCreate":1626313544773,"gmtModify":1635228934377,"authorId":3580972018907173,"author":{"id":3580972018907173,"idStr":"3580972018907173","authorId":3580972018907173,"name":"股海摩西","avatar":"https://static.tigerbbs.com/b4b3b2e60ed720da92ef4a446dcdaaf4","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":144730289,"type":1,"supId":0,"prevId":0,"content":"Zan","text":"Zan","html":"Zan"}],"langContent":"EN"},{"id":144795621,"gmtCreate":1626313412963,"gmtModify":1703757648105,"author":{"id":"127348458410217","authorId":"127348458410217","name":"麦基Zzzz","avatar":"https://static.tigerbbs.com/d8e889d499728bdd8d7c38817f7c1b94","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"127348458410217","idStr":"127348458410217"},"htmlText":"加強針？不是混打嗎？","listText":"加強針？不是混打嗎？","text":"加強針？不是混打嗎？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/144795621","repostId":1134354713,"repostType":4,"repost":{"id":"1134354713","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626313344,"share":"https://ttm.financial/m/news/1134354713?lang=&edition=fundamental","pubTime":"2021-07-15 09:42","market":"hk","language":"zh","title":"复星医药AH齐涨，传新冠疫苗通过专家评审","url":"https://stock-news.laohu8.com/highlight/detail?id=1134354713","media":"老虎资讯综合","summary":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经","content":"<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药AH齐涨，传新冠疫苗通过专家评审</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药AH齐涨，传新冠疫苗通过专家评审\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-07-15 09:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>7月15日，<a href=\"https://laohu8.com/S/02196\">复星医药</a>港股盘初大涨涨近7%，报61.3港元；<a href=\"https://laohu8.com/S/600196\">复星医药</a>A股涨逾5%，报68.17元。</p>\n<p>据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。</p>\n<p>复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。</p>\n<p><img src=\"https://static.tigerbbs.com/fcda9ea7ea213d3473fb919157b59bc5\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/eb875ce2002f9e31d921cfdc9eadf9b4\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6abbd3fc26184cc69ef95a83e11f6419","relate_stocks":{"150130":"医药A","600196":"复星医药","02196":"复星医药"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134354713","content_text":"7月15日，复星医药港股盘初大涨涨近7%，报61.3港元；复星医药A股涨逾5%，报68.17元。\n据财新，复星医药在股东大会上回复投资人问询时表示，国家药监局对mRNA新冠疫苗“复必泰”的审定工作已经基本完成，专家评审已经通过了，目前正在加紧进行行政审批阶段。\n复星医药已与BioNTech提前启动生产准备工作，复必泰疫苗一旦获批，就能第一时间供应到国内；知情人士称，未来，复必泰在国内很可能会作为加强针使用，免费接种。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":24,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}